Fundz

BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer

PUBLIC · BCLIJul 12, 2023

Position

Chief Medical Officer

Company

Brainstorm Cell Therapeutics

Bob Dagher
bob.dagher@brainstorm-cell.com
New YorkBiotechnologyHealth CareTherapeuticsresearch

Description

BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced the appointment of Bob Dagher, MD, as Executive Vice President and Chief Development Officer effective July 17, 2023. Dr

Quick answer

BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer (July 12, 2023). Brainstorm Cell Therapeutics is based in New York, New York, United States.

Who is the new Chief Medical Officer at Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics named Bob Dagher Chief Medical Officer, announced July 12, 2023.
What did Brainstorm Cell Therapeutics announce on July 12, 2023?
BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced the appointment of Bob Dagher, MD, as Executive Vice President and Chief Development Officer effective July 17, 2023.
What does Brainstorm Cell Therapeutics do?
BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases.
Where is Brainstorm Cell Therapeutics based?
Brainstorm Cell Therapeutics is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
Verastem Oncology (July 11, 2023), Elevation Oncology (July 13, 2023), Arbutus (July 11, 2023) and Rarebase (July 13, 2023) also announced leadership changes within 45 days of Brainstorm Cell Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and research

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Brainstorm Cell Therapeutics, and when

A new leader at Brainstorm Cell Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Brainstorm Cell Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Brainstorm Cell Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Brainstorm Cell Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Brainstorm Cell Therapeutics

Location

1325 Avenue of Americas, 28th Floor

New York, New York, United States

About

BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI) is a leading developer of autologous adult stem cell therapies for debilitating neurodegenerative diseases. The company's proprietary NurOwn® platform uses autologous mesenchymal stem cells (MSCs) to produce neurotrophic factor-secreting cells (MSC-NTF cells), designed to deliver targeted biological signals that modulate neuroinflammation and promote neuroprotection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Brainstorm Cell Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Chaim
Senior decision-maker at this company
••••••••@••••••••

See Chaim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Brainstorm Cell Therapeutics's next move

Learn about Strategic plan

Brainstorm Cell Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.